£79.00

It has never been this cheap. We have no record of a lower price.

£79 today · cheaper than every other day in the last 3 months

NYU Press Contraceptive Risk: The FDA, Depo-Provera, and the Politics of Experimental Medicine: 12 (Biopolitics)

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 73 days · 73 data points (no recent data)

Historical
Generating forecast…
£79.00 £75.05 £76.63 £78.21 £79.79 £81.37 £82.95 26 July 2026 13 August 2026 31 August 2026 18 September 2026 06 October 2026
View at Amazon ↗

Price data last checked 18 day(s) ago - will refresh soon

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 73 days • 1 price levels

Days at Price
73 days 0 18 37 55 73 £79 Days at Price

Price Analysis

Most common price: £79 (73 days, 100.0%)

Price range: £79 - £79

Price levels: 1 different prices over 73 days

Description

The story of Depo-Provera joins the national struggle over the drug's FDA approval to the state legal issues raised by its contraceptive and criminal justice uses. Depo-Provera is known as an injectable hormonal birth control method, but few are familiar with its dark and complicated history. Depo-Provera was tested on women since the mid-1960s without their informed consent until it was FDA-approved in 1992, but never FDA-approved as chemical castration for male sex offenders. Contraceptive Risk is William Green's landmark study of Depo-Provera. Based on a fascinating combination of archival materials and interviews, the book is framed as three interconnected stories told by Judith Weisz, who chaired the FDA's Public Board of Inquiry on Depo-Provera, a scientific court; by Anne MacMurdo who brought a products liability suit against Upjohn, the drug's manufacturer, for the deleterious side effects she suffered from the drug's use; and by Roger Gauntlett, an Upjohn heir who, when he was convicted of sexual assault, refused to take a dose of his family's own medicine as a probation condition. Together these three stories of Depo-Provera's convoluted fifty year odyssey call for a paradigm shift in pharmaceutical drug development. Contraceptive Risk is a thoroughly researched and engrossing approach to the scientific, political and institutional forces involved in health law and policy, as well as the multifaceted politics of measuring risk.

Product Specifications

Format
hardcover
Domain
Amazon UK
Release Date
02 May 2017
Listed Since
08 October 2016

Barcode

No barcode data available

Similar Products You Might Like

Contraception: Unmet Needs, Existing Options & New Technologies
97% match

Contraception: Unmet Needs, Existing Options & New Technologies

Nova Science Publishers Inc

£85.05 18 Sep 2026
Ethical, Efficacy and Safety Issues in Contraception (Reproductive Medicine for Clinicians, 4)
97% match

Ethical, Efficacy and Safety Issues in Contraception (Reproductive Medicine for Clinicians, 4)

Springer

£95.74 24 Sep 2026
The 2023-2028 Outlook for Contraceptive Pills in the United States
96% match

The 2023-2028 Outlook for Contraceptive Pills in the United States

£520.00 22 Aug 2026
2023-2028 Contraceptive Drugs Outlook United States
96% match

2023-2028 Contraceptive Drugs Outlook United States

£520.00 22 Oct 2026
The 2016-2021 Outlook for Oral Contraceptive Preparations of Hormones and Synthetic Substitute Pharmaceuticals in the United States
96% match

The 2016-2021 Outlook for Oral Contraceptive Preparations of Hormones and Synthetic Substitute Pharmaceuticals in the United States

£595.00 11 Sep 2026
The 2023-2028 Outlook for Female Contraceptives in the United States
96% match

The 2023-2028 Outlook for Female Contraceptives in the United States

£520.00 11 Aug 2026
Contraception en milieu estudiantin à Ouagadougou ( Burkina Faso): En milieu estudiantin des universités publiques de la ville de Ouagadougou (Burkina Faso)
96% match

Contraception en milieu estudiantin à Ouagadougou ( Burkina Faso): En milieu estudiantin des universités publiques de la ville de Ouagadougou (Burkina Faso)

ÉDITIONS UNIVERSITAIRES EUROPÉENNES

£59.00 22 Sep 2026
The Family Planning Association and Contraceptive Science and Technology in Mid-Twentieth-Century Britain (Medicine and Biomedical Sciences in Modern History)
96% match

The Family Planning Association and Contraceptive Science and Technology in Mid-Twentieth-Century Britain (Medicine and Biomedical Sciences in Modern History)

Palgrave

£100.11 25 Sep 2026
The Family Planning Association and Contraceptive Science and Technology in Mid-Twentieth-Century Britain (Medicine and Biomedical Sciences in Modern History)
96% match

The Family Planning Association and Contraceptive Science and Technology in Mid-Twentieth-Century Britain (Medicine and Biomedical Sciences in Modern History)

MACMILLAN

£99.15 24 Sep 2026
The 2023-2028 Outlook for Contraceptive Human Reproductive Technologies in the United States
96% match

The 2023-2028 Outlook for Contraceptive Human Reproductive Technologies in the United States

£520.00 15 Aug 2026
The 2023-2028 Outlook for Contraceptives in the United States
96% match

The 2023-2028 Outlook for Contraceptives in the United States

£520.00 22 Aug 2026
The 2023-2028 Outlook for Contraceptive Pills in Japan
96% match

The 2023-2028 Outlook for Contraceptive Pills in Japan

£495.00 20 Aug 2026
The 2023-2028 Outlook for Female Contraceptives in India
96% match

The 2023-2028 Outlook for Female Contraceptives in India

£515.00 26 Aug 2026
The 2023-2028 Outlook for Contraceptive Devices in India
96% match

The 2023-2028 Outlook for Contraceptive Devices in India

£515.00 05 Sep 2026
Birth Control in Nineteenth-Century England (Routledge Revivals)
96% match

Birth Control in Nineteenth-Century England (Routledge Revivals)

Routledge

£117.23 19 Sep 2026
Disparités Géoculturelles du non recours à la contraception moderne: Des femmes en union au Cameroun Rural
96% match

Disparités Géoculturelles du non recours à la contraception moderne: Des femmes en union au Cameroun Rural

ÉDITIONS UNIVERSITAIRES EUROPÉENNES

£63.00 22 Sep 2026
The 2023-2028 Outlook for Contraceptive Drugs in Japan
96% match

The 2023-2028 Outlook for Contraceptive Drugs in Japan

£495.00 14 Aug 2026
The 2023-2028 Outlook for Contraceptive Human Reproductive Technologies in India
96% match

The 2023-2028 Outlook for Contraceptive Human Reproductive Technologies in India

£515.00 19 Aug 2026
The 2023-2028 Outlook for Emergency Contraceptive Pills in India
96% match

The 2023-2028 Outlook for Emergency Contraceptive Pills in India

£515.00 26 Aug 2026
The 2023-2028 Outlook for Hormonal Contraceptives in Japan
96% match

The 2023-2028 Outlook for Hormonal Contraceptives in Japan

£495.00 11 Aug 2026
The 2016-2021 Outlook for Oral Contraceptive Preparations of Hormones and Synthetic Substitute Pharmaceuticals in Japan
96% match

The 2016-2021 Outlook for Oral Contraceptive Preparations of Hormones and Synthetic Substitute Pharmaceuticals in Japan

£595.00 06 Sep 2026
Contraception:: Les femmes se voient-elles refuser le droit à l'autodécision ?
96% match

Contraception:: Les femmes se voient-elles refuser le droit à l'autodécision ?

ÉDITIONS UNIVERSITAIRES EUROPÉENNES

£48.00 26 Sep 2026
The 2023-2028 Outlook for Female Contraceptives in Japan
96% match

The 2023-2028 Outlook for Female Contraceptives in Japan

£495.00 27 Sep 2026
Contraception: An Herbal Medicine Approach of Citrus medica Seeds
96% match

Contraception: An Herbal Medicine Approach of Citrus medica Seeds

LAP Lambert Academic Publishing

£66.00 18 Sep 2026